article Open AccessTop 1% cited

The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: Clinical and regulatory implications Report on a Policy Conference of the European Society of Cardiology

Cardiovascular Research · 2000 · Vol. 47(2) · pp. 219–233

Abstract

1 1.Preamble mal presentations.The speakers were chosen for their particular competence in the relevant field.Furthermore, The Policy Conference on The Potential for QT selected topics were discussed in detail in separate work-Prolongation and Pro-arrhythmia by Non-anti-arrhythmic shops.This document represents the executive summary of Drugs.

Cardiac electrophysiology and arrhythmias Receptor Mechanisms and Signaling Ion channel regulation and functionMedicineQT intervalProlongationCardiologyLong QT syndromeInternal medicineCardiac arrhythmiaAnti-Arrhythmia AgentsClinical pharmacologyPharmacology

MeSH terms

Action PotentialsAnimalsAnti-Arrhythmia AgentsAnti-Bacterial AgentsCardiologyClinical Trials as TopicDisease Models, AnimalDrug and Narcotic ControlEuropeHumansProduct Surveillance, PostmarketingResearchSocieties, MedicalAntipsychotic AgentsVasodilator Agents

Citations

484

FWCI

18.91

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Antipsychotic-Related QTc Prolongation, Torsade de Pointes and Sudden Death